Eric O’Brien
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Acute Myeloid Leukemia Research 9
- Hematopoietic Stem Cell Transplantation 2
- Chronic Myeloid Leukemia Treatments 1
-
- Protein Degradation and Inhibitors 3
- Histone Deacetylase Inhibitors Research 2
- RNA Interference and Gene Delivery 2
- Co-authors
- Benjamin Mizukawa (8 shared papers)Mark Wunderlich (7 shared papers)James C. Mulloy (6 shared papers)John P. Perentesis (11 shared papers)Nicole Manning (2 shared papers)H. Leighton Grimes (3 shared papers)Toshio Kitamura (3 shared papers)Susumu Goyama (3 shared papers)
- Journals
- Blood (5 papers)Nature Communications (2 papers)PLoS ONE (2 papers)IEEE Security & Privacy (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesJapanSaudi Arabia
In The Last Decade
Eric O’Brien
16 papers receiving 202 citations
Peers
Comparison fields: 5 of 50
- Hematology 87
- Genetics 24
- Oncology 51
- Immunology 36
- Cancer Research 23
Countries citing papers authored by Eric O’Brien
This map shows the geographic impact of Eric O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric O’Brien more than expected).
Fields of papers citing papers by Eric O’Brien
This network shows the impact of papers produced by Eric O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric O’Brien. The network helps show where Eric O’Brien may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 37 | |
| 2 | 2019 | 34 | |
| 3 | 2020 | 24 | |
| 4 | 2021 | 21 | |
| 5 | 2018 | 21 | |
| 6 | 2019 | 20 | |
| 7 | 2016 | 16 | |
| 8 | 2023 | 12 | |
| 9 | 2024 | 9 | |
| 10 | 2021 | 3 | |
| 11 | 2025 | 1 | |
| 12 | 2025 | 1 | |
| 13 | 2013 | 1 | |
| 14 | 2018 | 1 | |
| 15 | 2016 | 1 | |
| 16 | 2013 | 1 | |
| 17 | 2024 | 0 |
About Eric O’Brien
Eric O’Brien is a scholar working on Hematology, Molecular Biology, Immunology, Cancer Research and Genetics, having authored 17 papers that have together received 203 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Protein Degradation and Inhibitors (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), RNA Interference and Gene Delivery (2 papers), Immune Cell Function and Interaction (2 papers) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Hematology (87 citations), Genetics (24 citations), Oncology (51 citations), Immunology (36 citations) and Cancer Research (23 citations). Eric O’Brien has collaborated with scholars based in United States, Japan and Saudi Arabia. Frequent co-authors include Benjamin Mizukawa, Mark Wunderlich, James C. Mulloy, John P. Perentesis, Nicole Manning, H. Leighton Grimes, Toshio Kitamura, Susumu Goyama, Yi Zheng and Daniel C. Moreira. Their work appears in journals such as Blood, Nature Communications, PLoS ONE, IEEE Security & Privacy and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.